Stay updated on Andecaliximab mFOLFOX6 in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Andecaliximab mFOLFOX6 in Gastric Cancer Clinical Trial page.

Latest updates to the Andecaliximab mFOLFOX6 in Gastric Cancer Clinical Trial page
- CheckyesterdayChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1 on an otherwise unchanged 403 Forbidden page.SummaryDifference0.2%

- Check8 days agoNo Change Detected
- Check14 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study record, indicating access is blocked, with the typical ClinicalTrials.gov header and footer shown on the error page.SummaryDifference18%

- Check21 days agoChange DetectedRevision label updated from v3.6.6 to v3.7.0 on the page, reflecting a newer version of the interface. This is a minor UI/version change and does not modify study data, eligibility criteria, or results.SummaryDifference0.0%

- Check36 days agoChange DetectedThe page's revision tag was updated from v3.6.5 to v3.6.6. This indicates a minor administrative update to the site's version metadata rather than changes to study details.SummaryDifference0.0%

- Check43 days agoChange DetectedA new line '2015 ( U.S. NIH Grant/Contract )' was added to the study's identifiers, indicating NIH funding for GS-US-296-1080.SummaryDifference0.0%

- Check57 days agoChange DetectedRevision updated from v3.6.4 to v3.6.5, signaling a small document-level update rather than a content change.SummaryDifference0.0%

Stay in the know with updates to Andecaliximab mFOLFOX6 in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Andecaliximab mFOLFOX6 in Gastric Cancer Clinical Trial page.